Study of KRYSTEXXA® (Pegloticase) Plus Methotrexate in Participants With Uncontrolled Gout
Clinical trial NCT03994731 · COMPLETED
Trial details
- NCT number
- NCT03994731
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-13
- Primary completion
- 2021-03-17
- Enrollment
- 152
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.